Back to the complete issue
Tuesday, 12 May 2020

CDC targeting Alfa Medical with USD 150 mn investment

INVESTMENT WATCH- CDC is looking at a USD 150 mn investment in labs and healthcare player Alfa -report. The UK’s CDC Group is looking at an investment of as much as USD 150 mn to acquire a minority stake in Alfa Medical Group, according to a report in Al Mal that cites Alfa Managing Director Adel Talaat. Talks are ongoing, and Taalat declined to get into specifics; a report earlier this week had put the value of the investment at USD 100 mn. Alfa also has interest from other parties eyeing minority stakes, the newspaper says. Reports in the domestic press had previously said that a transaction could close in the next few weeks.

CLARIFICATION- In our coverage of this story yesterday, we noted CDC’s past track record of investing in Egypt. Its investments in companies including snackfood giant Edita and leading labs group IDH, among others, were not made directly, but via funds managed by our friends at emerging markets private equity firm Actis. CDC has made 22 direct and indirect investments in Egypt, having also provided tier-2 capital to banks including CIB and made commitments to a venture capital fund managed by Sawari Ventures and a small- and midcap fund managed by Ezdehar.

Advisors: Matouk Bassiouny is CDC Group’s legal counsel, while Al Kamel Law Office and Serry Law Office are advising Alfa.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.